Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (431-440 of 894) with videos related to

Pageof 90
Sort By:
Hypertension (Dallas, Tex. : 1979)|July 22, 2009
Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapyPiero Ruggenenti, Dario Cattaneo, Giacomina Loriga, et al.
Therapeutic Drug Monitoring|October 14, 2006
Mycophenolic acid formulation affects cyclosporine pharmacokinetics in stable kidney transplant recipientsDario Cattaneo, Simona Merlini, Sara Baldelli, et al.
Lancet (London, England)|May 15, 2025
Guatemala's resolution on kidney health: a historic opportunityMarcello Tonelli, Masaomi Nangaku, Magdalena Machalska, et al.
International Journal of Cardiology|December 5, 2018
Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: A cross-sectional and longitudinal substudy of the ALADIN trialLetizia Spinelli, Antonio Pisani, Giuseppe Giugliano, et al.
The American Journal of Pathology|August 16, 2017
The Role of Angiotensin II in Parietal Epithelial Cell Proliferation and Crescent Formation in Glomerular DiseasesPaola Rizzo, Rubina Novelli, Cinzia Rota, et al.
Kidney International|April 23, 2002
Effect of combining ACE inhibitor and statin in severe experimental nephropathyCarla Zoja, Daniela Corna, Daniela Rottoli, et al.
Frontiers in Pharmacology|September 19, 2022
Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndromeAnnalisa Perna, Barbara Ruggiero, Manuel Alfredo Podestà, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2014
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKDGerald Schulman, Tomas Berl, Gerald J Beck, et al.
Journal of the American Society of Nephrology : JASN|April 9, 2016
Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney DiseaseTobias F Kröpelin, Dick de Zeeuw, Giuseppe Remuzzi, et al.
Kidney International|August 8, 2002
Effect of angiotensin II antagonism on the regression of kidney disease in the ratAndrea Remuzzi, Elena Gagliardini, Chiara Donadoni, et al.
Pageof 90

Showing results (431-440 of 894) with videos related to

Sort By:
Pageof 90
Hypertension (Dallas, Tex. : 1979)|July 22, 2009
Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapyPiero Ruggenenti, Dario Cattaneo, Giacomina Loriga, et al.
Therapeutic Drug Monitoring|October 14, 2006
Mycophenolic acid formulation affects cyclosporine pharmacokinetics in stable kidney transplant recipientsDario Cattaneo, Simona Merlini, Sara Baldelli, et al.
Lancet (London, England)|May 15, 2025
Guatemala's resolution on kidney health: a historic opportunityMarcello Tonelli, Masaomi Nangaku, Magdalena Machalska, et al.
International Journal of Cardiology|December 5, 2018
Left ventricular dysfunction in ADPKD and effects of octreotide-LAR: A cross-sectional and longitudinal substudy of the ALADIN trialLetizia Spinelli, Antonio Pisani, Giuseppe Giugliano, et al.
The American Journal of Pathology|August 16, 2017
The Role of Angiotensin II in Parietal Epithelial Cell Proliferation and Crescent Formation in Glomerular DiseasesPaola Rizzo, Rubina Novelli, Cinzia Rota, et al.
Kidney International|April 23, 2002
Effect of combining ACE inhibitor and statin in severe experimental nephropathyCarla Zoja, Daniela Corna, Daniela Rottoli, et al.
Frontiers in Pharmacology|September 19, 2022
Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndromeAnnalisa Perna, Barbara Ruggiero, Manuel Alfredo Podestà, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2014
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKDGerald Schulman, Tomas Berl, Gerald J Beck, et al.
Journal of the American Society of Nephrology : JASN|April 9, 2016
Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney DiseaseTobias F Kröpelin, Dick de Zeeuw, Giuseppe Remuzzi, et al.
Kidney International|August 8, 2002
Effect of angiotensin II antagonism on the regression of kidney disease in the ratAndrea Remuzzi, Elena Gagliardini, Chiara Donadoni, et al.
Pageof 90